T. Oita

[Deficiency of creatine kinase MM fraction].

K. Fukuda, K. Nakamura, H. Yamamichi, 1988, Rinsho byori. The Japanese journal of clinical pathology.

[Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma].

S. Kasakura, T. Oita, K. Sakizono, 1998, Rinsho byori. The Japanese journal of clinical pathology.

IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome

H. Arima, Takayuki Takahashi, D. Inoue, 2013, Annals of Hematology.

Hepatic encephalopathy in primary human immunodeficiency virus type 1 (HIV-1) infection.

Takayuki Takahashi, T. Ishihara, A. Matsushita, 2002, Internal medicine.

[Demonstration of PIVKA-II and AFP production by gastric cancer by indirect immunoenzymatic staining of paraffin sections].

M. Kudo, K. Nakamura, S. Kasakura, 1991, Rinsho byori. The Japanese journal of clinical pathology.

[Clinical usefulness of serum PIVKA-II levels determined by ECLIA system as a tumor maker for hepatocellular carcinoma].

S. Kasakura, T. Oita, K. Sakizono, 1998, Rinsho byori. The Japanese journal of clinical pathology.

Successful Treatment of γ-Heavy-Chain Disease with Rituximab and Fludarabine

H. Arima, Takayuki Takahashi, D. Inoue, 2012, Acta Haematologica.

[Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].

Takayuki Takahashi, Akinori Maeda, T. Oita, 2003, Rinsho byori. The Japanese journal of clinical pathology.

[Studies on the mechanism of elevation of serum PIVKA-II levels in alcoholic liver cirrhosis].

M. Eto, Hiroshi Takegawa, S. Kasakura, 2002, Rinsho byori. The Japanese journal of clinical pathology.